These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16997929)

  • 1. A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies.
    Lee CP; Chertow GM; Zenios SA
    Med Decis Making; 2006; 26(5):535-49. PubMed ID: 16997929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].
    Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H
    Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care.
    Manns B; Meltzer D; Taub K; Donaldson C
    Health Econ; 2003 Nov; 12(11):949-58. PubMed ID: 14601157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of alternative treatments in end-stage renal disease.
    Karlberg I
    Transplant Proc; 1992 Feb; 24(1):335. PubMed ID: 1539301
    [No Abstract]   [Full Text] [Related]  

  • 7. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
    Anantharaman P; Moss AH
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventable kidney failure: the cost of diabetes neglect?
    Endre ZH; Beaven D; Buttimore A
    N Z Med J; 2006 Dec; 119(1246):U2338. PubMed ID: 17151712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of sevelamer in patients with end-stage renal disease.
    Manns B; Klarenbach S; Lee H; Culleton B; Shrive F; Tonelli M
    Nephrol Dial Transplant; 2007 Oct; 22(10):2867-78. PubMed ID: 17595182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical and economic strategies of maintenance dialysis in the UK and Nordic Countries.
    Cantaluppi A; East P
    J Nephrol; 2000; 13 Suppl 3():S10-5. PubMed ID: 11132025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard.
    Lee CP; Chertow GM; Zenios SA
    Value Health; 2009; 12(1):80-7. PubMed ID: 19911442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal transplantation without dialysis: better results at a lower cost?
    John GT; Viswanathan S
    Natl Med J India; 2001; 14(4):224. PubMed ID: 11547530
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal transplantation costs: an economic analysis and comparison with dialysis costs.
    Aranzabal J; Pérdigo L; Mijares J; Villar F
    Transplant Proc; 1991 Oct; 23(5):2574. PubMed ID: 1926487
    [No Abstract]   [Full Text] [Related]  

  • 18. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The STARRT trial: a cost comparison of optimal vs sub-optimal initiation of dialysis in Canada.
    Piwko C; Vicente C; Marra L; Jivraj F; Appel E; Wolpin J; Camacho F; Mendelssohn DC; McFarlane PA
    J Med Econ; 2012; 15(1):96-104. PubMed ID: 21988636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.